| 摘要 |
FIELD: medicine, pharmaceutics.SUBSTANCE: invention refers to biochemistry and represents a kit for preventing or treating bacterial meningitis, containing: (a) conjugated capsular saccharide originating from N. meningitidisserogroup A, in the lyophilised form; and (b) capsular saccharides originating from N. meningitidisserogroups C, W135 and Y, in the liquid form wherein the relation (wt / wt) of the saccharide serogroup A and the saccharide serogroup C exceeds 1.EFFECT: invention enables preparing effective vaccines of the above kit.29 cl, 19 dwg |
